Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

  • 1, 2,
  • 1,
  • 2,
  • 1,
  • 2 and
  • 1Email author
Contributed equally
Breast Cancer Research201517:96

https://doi.org/10.1186/s13058-015-0597-9

  • Received: 28 May 2014
  • Accepted: 21 July 2014
  • Published:

The original article was published in Breast Cancer Research 2011 13:R88

Correction

While compiling the article [1] one of the authors was inadvertently omitted from the author list. This author, Rhiannon French, has been included in the corrected author list above.

Notes

Declarations

Acknowledgements

We thank Christien Gabriel and Dawn Roberts for technical support. This study was funded by a Tenovus PhD scholarship (LP), seed-corn funding from the Breast Cancer Campaign (RC) and additional part-funding from CR-UK (ME) and BBSRC (NO). RC and ME are RC-UK Research Fellows.

Authors’ Affiliations

(1)
Life Sciences Building, Cardiff University School of Biosciences, Museum Avenue, Cardiff, CF10 3AX, Wales, UK
(2)
Department of Infection, Immunity and Biochemistry, Cardiff University School of Medicine, Heath Park Campus, Cardiff, CF14 4XN, Wales, UK

Reference

  1. Piggott L, Omidvar N, Martí Pérez S, Eberl M, Clarkson RWE. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Canc Res. 2011;13:R88.View ArticleGoogle Scholar

Copyright

Advertisement